Post-approval studies (Phase 4)UnknownNCT01565096
What this trial is testing
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
Who this might be right for
Diabetes Mellitus Type II
ikfe-CRO GmbH 44